Developing Drugs for Rare Diseases: Pointers and Pitfalls
from LifeSci Partners Podcast Hosted by LifeSci Partners.com
There are approximately 30 million individuals in the U.S. currently living with one of at least 7,000 rare diseases. The National Organization for Rare Disorders estimates that more than 90% of these patients are still without an FDA-approved treatment. Dr. Jane Larkindale, VP of Clinical Science at PepGen, Inc. is looking to change that, and she has both the experience and passion to show you how.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of LifeSci Partners Podcast?
This episode is 34 minutes long.
When was this LifeSci Partners Podcast episode published?
This episode was published on February 28, 2022.
Can I download this LifeSci Partners Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.